| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 53 | 2018 | 415 | 7.270 |
Why?
|
| Receptors, Immunologic | 29 | 2017 | 1418 | 3.650 |
Why?
|
| Pneumonia, Pneumococcal | 8 | 2019 | 133 | 2.280 |
Why?
|
| Orthomyxoviridae Infections | 7 | 2018 | 255 | 2.060 |
Why?
|
| Lung | 92 | 2021 | 10101 | 1.950 |
Why?
|
| Phagocytosis | 37 | 2017 | 1530 | 1.930 |
Why?
|
| Scavenger Receptors, Class A | 9 | 2017 | 52 | 1.880 |
Why?
|
| Receptors, Scavenger | 16 | 2017 | 123 | 1.740 |
Why?
|
| Air Pollutants | 25 | 2017 | 2916 | 1.650 |
Why?
|
| Gelsolin | 3 | 2019 | 189 | 1.640 |
Why?
|
| Asthma | 31 | 2017 | 6291 | 1.400 |
Why?
|
| Francisella tularensis | 5 | 2020 | 60 | 1.350 |
Why?
|
| Macrophages | 34 | 2020 | 5802 | 1.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 30 | 2016 | 4355 | 1.040 |
Why?
|
| Influenza, Human | 4 | 2018 | 1541 | 1.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 38 | 2017 | 760 | 0.860 |
Why?
|
| Endotoxins | 6 | 2017 | 519 | 0.840 |
Why?
|
| Mice, Inbred BALB C | 36 | 2017 | 6231 | 0.830 |
Why?
|
| Animals | 244 | 2024 | 169285 | 0.820 |
Why?
|
| Titanium | 14 | 2014 | 495 | 0.800 |
Why?
|
| Mice | 131 | 2024 | 82049 | 0.800 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2015 | 706 | 0.790 |
Why?
|
| Host-Pathogen Interactions | 3 | 2020 | 1469 | 0.780 |
Why?
|
| Cytokines | 30 | 2022 | 7452 | 0.770 |
Why?
|
| Respiratory Hypersensitivity | 9 | 2007 | 272 | 0.760 |
Why?
|
| Neutrophils | 49 | 2018 | 3786 | 0.760 |
Why?
|
| Nitric Oxide Synthase | 24 | 2009 | 911 | 0.750 |
Why?
|
| Flow Cytometry | 30 | 2016 | 5902 | 0.750 |
Why?
|
| Bronchial Hyperreactivity | 11 | 2014 | 301 | 0.740 |
Why?
|
| Lipopolysaccharides | 23 | 2024 | 2222 | 0.740 |
Why?
|
| Endotoxemia | 3 | 2022 | 198 | 0.730 |
Why?
|
| Maternal Exposure | 8 | 2017 | 1096 | 0.710 |
Why?
|
| Nitric Oxide | 18 | 2014 | 2149 | 0.710 |
Why?
|
| Immunologic Factors | 3 | 2019 | 1596 | 0.710 |
Why?
|
| Particulate Matter | 14 | 2014 | 2617 | 0.690 |
Why?
|
| Pneumonia | 15 | 2018 | 2163 | 0.690 |
Why?
|
| Minor Histocompatibility Antigens | 4 | 2020 | 303 | 0.690 |
Why?
|
| Sexual Maturation | 2 | 2017 | 258 | 0.640 |
Why?
|
| Allergens | 10 | 2013 | 1443 | 0.630 |
Why?
|
| Monokines | 8 | 2000 | 71 | 0.630 |
Why?
|
| Immunity, Innate | 14 | 2016 | 3080 | 0.630 |
Why?
|
| Golgi Apparatus | 1 | 2020 | 406 | 0.620 |
Why?
|
| Monocytes | 7 | 2020 | 2605 | 0.610 |
Why?
|
| Receptors, Lipoprotein | 4 | 2001 | 88 | 0.600 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2017 | 452 | 0.600 |
Why?
|
| Interferon-gamma | 14 | 2017 | 3161 | 0.600 |
Why?
|
| Microspheres | 2 | 2014 | 788 | 0.600 |
Why?
|
| Ozone | 4 | 2013 | 496 | 0.600 |
Why?
|
| Disease Susceptibility | 12 | 2018 | 1793 | 0.590 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2009 | 454 | 0.580 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 2011 | 705 | 0.580 |
Why?
|
| Autophagy | 4 | 2020 | 1351 | 0.570 |
Why?
|
| Oxidants | 6 | 2007 | 168 | 0.570 |
Why?
|
| Inhalation Exposure | 7 | 2014 | 432 | 0.560 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 213 | 0.550 |
Why?
|
| Streptococcus pneumoniae | 6 | 2016 | 764 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 42 | 2021 | 22380 | 0.540 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2020 | 572 | 0.530 |
Why?
|
| Acute Lung Injury | 4 | 2018 | 378 | 0.510 |
Why?
|
| Gene Expression Profiling | 13 | 2024 | 9540 | 0.510 |
Why?
|
| Macrophages, Peritoneal | 4 | 2011 | 244 | 0.510 |
Why?
|
| Orthomyxoviridae | 1 | 2017 | 148 | 0.510 |
Why?
|
| Pneumonia, Bacterial | 2 | 2017 | 320 | 0.490 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2000 | 462 | 0.490 |
Why?
|
| Pulmonary Alveoli | 14 | 2014 | 665 | 0.480 |
Why?
|
| Carbon | 8 | 2014 | 672 | 0.470 |
Why?
|
| Disease Models, Animal | 34 | 2021 | 18349 | 0.460 |
Why?
|
| Cricetinae | 18 | 2011 | 2423 | 0.450 |
Why?
|
| Interleukin-8 | 5 | 2008 | 705 | 0.450 |
Why?
|
| Dendritic Cells | 6 | 2017 | 2747 | 0.440 |
Why?
|
| Particle Size | 14 | 2014 | 1651 | 0.440 |
Why?
|
| Animals, Newborn | 12 | 2017 | 2683 | 0.440 |
Why?
|
| Bronchitis | 5 | 2012 | 194 | 0.440 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2018 | 1339 | 0.430 |
Why?
|
| Amino Acid Oxidoreductases | 9 | 1995 | 149 | 0.390 |
Why?
|
| Publications | 1 | 2014 | 195 | 0.380 |
Why?
|
| Rats | 68 | 2024 | 23782 | 0.380 |
Why?
|
| Staphylococcus aureus | 5 | 2022 | 1430 | 0.370 |
Why?
|
| Mice, Knockout | 33 | 2016 | 14488 | 0.360 |
Why?
|
| Cells, Cultured | 32 | 2021 | 19025 | 0.360 |
Why?
|
| Sepsis | 4 | 2024 | 2608 | 0.360 |
Why?
|
| Cell Line | 19 | 2020 | 15602 | 0.360 |
Why?
|
| Inflammation | 22 | 2024 | 10873 | 0.360 |
Why?
|
| Interleukin-13 | 3 | 2017 | 390 | 0.360 |
Why?
|
| Hydrogen Peroxide | 8 | 2011 | 741 | 0.350 |
Why?
|
| Ovalbumin | 12 | 2017 | 677 | 0.350 |
Why?
|
| Antigens, Differentiation | 3 | 2007 | 921 | 0.350 |
Why?
|
| Communicable Diseases | 1 | 2018 | 873 | 0.350 |
Why?
|
| Drug Discovery | 1 | 2018 | 1068 | 0.340 |
Why?
|
| Opsonin Proteins | 5 | 1996 | 144 | 0.340 |
Why?
|
| Immunity, Maternally-Acquired | 2 | 2007 | 112 | 0.340 |
Why?
|
| DNA Methylation | 7 | 2017 | 4428 | 0.330 |
Why?
|
| Oxidative Stress | 9 | 2014 | 3140 | 0.330 |
Why?
|
| Actins | 1 | 2017 | 2064 | 0.330 |
Why?
|
| Estrogens | 3 | 2014 | 1536 | 0.330 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2007 | 1354 | 0.320 |
Why?
|
| Reactive Oxygen Species | 8 | 2015 | 2152 | 0.320 |
Why?
|
| Ecotoxicology | 1 | 2008 | 8 | 0.320 |
Why?
|
| Macrophage Activation | 8 | 2016 | 557 | 0.320 |
Why?
|
| RNA, Messenger | 20 | 2017 | 12801 | 0.320 |
Why?
|
| Fluoresceins | 6 | 1999 | 235 | 0.310 |
Why?
|
| Interleukin-4 | 4 | 2009 | 1156 | 0.310 |
Why?
|
| Candida albicans | 1 | 2011 | 375 | 0.310 |
Why?
|
| Chemokine CXCL2 | 10 | 2002 | 105 | 0.310 |
Why?
|
| Interleukin-10 | 5 | 2022 | 1184 | 0.300 |
Why?
|
| Interleukin-12 | 3 | 2006 | 577 | 0.300 |
Why?
|
| Immunity | 2 | 2012 | 1003 | 0.300 |
Why?
|
| Pneumonia, Aspiration | 10 | 2001 | 145 | 0.300 |
Why?
|
| Mothers | 4 | 2010 | 2209 | 0.290 |
Why?
|
| Eosinophilic Granuloma | 2 | 2017 | 27 | 0.290 |
Why?
|
| Reperfusion Injury | 16 | 2003 | 1039 | 0.290 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2007 | 40 | 0.280 |
Why?
|
| Chemokines | 9 | 2015 | 963 | 0.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2017 | 2539 | 0.280 |
Why?
|
| Ischemia | 22 | 2000 | 1900 | 0.280 |
Why?
|
| Antigens, CD | 9 | 2013 | 4035 | 0.280 |
Why?
|
| Neutrophil Activation | 2 | 2007 | 180 | 0.280 |
Why?
|
| Tetradecanoylphorbol Acetate | 6 | 2020 | 826 | 0.270 |
Why?
|
| Epithelial Cells | 7 | 2015 | 3703 | 0.270 |
Why?
|
| Glucocorticoids | 3 | 2017 | 2167 | 0.270 |
Why?
|
| Mannose-Binding Lectins | 2 | 2009 | 101 | 0.270 |
Why?
|
| Smoke | 3 | 2014 | 242 | 0.270 |
Why?
|
| Aerosols | 9 | 2014 | 634 | 0.260 |
Why?
|
| Receptors, Cell Surface | 10 | 2014 | 2819 | 0.260 |
Why?
|
| MicroRNAs | 3 | 2017 | 3803 | 0.260 |
Why?
|
| Signal Transduction | 14 | 2020 | 23648 | 0.260 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 825 | 0.250 |
Why?
|
| Microbial Viability | 2 | 2019 | 237 | 0.250 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 306 | 0.250 |
Why?
|
| Methacholine Chloride | 9 | 2014 | 220 | 0.250 |
Why?
|
| Vehicle Emissions | 3 | 2017 | 651 | 0.250 |
Why?
|
| Chemokines, CXC | 4 | 1996 | 420 | 0.250 |
Why?
|
| CpG Islands | 4 | 2017 | 1208 | 0.240 |
Why?
|
| Membrane Proteins | 8 | 2015 | 7876 | 0.240 |
Why?
|
| Female | 97 | 2021 | 397187 | 0.240 |
Why?
|
| Lectins, C-Type | 3 | 2014 | 594 | 0.240 |
Why?
|
| T-Lymphocytes | 10 | 2007 | 10266 | 0.230 |
Why?
|
| Protein Kinases | 2 | 2008 | 1611 | 0.230 |
Why?
|
| Free Radical Scavengers | 6 | 2004 | 213 | 0.220 |
Why?
|
| Stress, Psychological | 3 | 2014 | 4530 | 0.220 |
Why?
|
| Borrelia burgdorferi | 2 | 2017 | 183 | 0.220 |
Why?
|
| Hindlimb | 15 | 2001 | 516 | 0.220 |
Why?
|
| Species Specificity | 3 | 2024 | 2415 | 0.220 |
Why?
|
| DNA-Binding Proteins | 3 | 2020 | 9617 | 0.220 |
Why?
|
| Chemotaxis, Leukocyte | 7 | 1996 | 660 | 0.210 |
Why?
|
| Mesocricetus | 8 | 1999 | 256 | 0.210 |
Why?
|
| Recombinant Proteins | 14 | 2019 | 6512 | 0.210 |
Why?
|
| Environmental Exposure | 5 | 2014 | 4543 | 0.210 |
Why?
|
| Male | 110 | 2021 | 364731 | 0.210 |
Why?
|
| Respiratory Sounds | 2 | 2017 | 702 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2830 | 0.210 |
Why?
|
| Sex Characteristics | 2 | 2017 | 2649 | 0.210 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 843 | 0.210 |
Why?
|
| Humans | 108 | 2024 | 768171 | 0.210 |
Why?
|
| Oils | 1 | 2002 | 54 | 0.200 |
Why?
|
| Base Sequence | 13 | 2017 | 12422 | 0.200 |
Why?
|
| Respiratory Burst | 8 | 2000 | 110 | 0.200 |
Why?
|
| Lung Injury | 5 | 2017 | 433 | 0.200 |
Why?
|
| Pregnancy | 20 | 2017 | 30255 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2017 | 252 | 0.200 |
Why?
|
| Cell Death | 2 | 2020 | 1680 | 0.190 |
Why?
|
| Oxidants, Photochemical | 1 | 2002 | 77 | 0.190 |
Why?
|
| Morpholines | 3 | 2000 | 584 | 0.190 |
Why?
|
| Nanostructures | 2 | 2019 | 553 | 0.190 |
Why?
|
| ADAM Proteins | 2 | 2013 | 242 | 0.190 |
Why?
|
| Air Pollutants, Occupational | 2 | 2014 | 406 | 0.190 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2021 | 8 | 0.190 |
Why?
|
| Milk, Human | 1 | 2006 | 490 | 0.190 |
Why?
|
| Metals, Heavy | 1 | 2002 | 149 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2011 | 2682 | 0.180 |
Why?
|
| Dust | 2 | 2001 | 488 | 0.180 |
Why?
|
| Coal | 2 | 1999 | 122 | 0.180 |
Why?
|
| Hypersensitivity | 2 | 2010 | 1172 | 0.180 |
Why?
|
| Growth Substances | 4 | 1996 | 760 | 0.180 |
Why?
|
| Capillary Permeability | 8 | 2016 | 772 | 0.180 |
Why?
|
| Cell Survival | 5 | 2020 | 5789 | 0.180 |
Why?
|
| Quartz | 5 | 1999 | 23 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 26 | 2002 | 8142 | 0.180 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 733 | 0.180 |
Why?
|
| Bone Marrow Transplantation | 8 | 2005 | 2709 | 0.180 |
Why?
|
| Bodily Secretions | 1 | 2020 | 28 | 0.180 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 3833 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 999 | 0.170 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 11930 | 0.170 |
Why?
|
| Respiratory System | 3 | 2014 | 564 | 0.170 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2973 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 6 | 2017 | 5797 | 0.170 |
Why?
|
| Herpes Simplex | 4 | 2013 | 470 | 0.170 |
Why?
|
| Immunoglobulin E | 10 | 2017 | 1506 | 0.170 |
Why?
|
| Complement Membrane Attack Complex | 5 | 1999 | 105 | 0.170 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2000 | 64 | 0.170 |
Why?
|
| Pneumonia, Viral | 4 | 2011 | 3238 | 0.170 |
Why?
|
| Antigens, Surface | 5 | 1989 | 1617 | 0.160 |
Why?
|
| Pulmonary Surfactants | 2 | 2000 | 169 | 0.160 |
Why?
|
| Occupational Exposure | 3 | 2014 | 1807 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2020 | 137 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 14 | 2007 | 9262 | 0.160 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2020 | 146 | 0.160 |
Why?
|
| Antioxidants | 5 | 2006 | 1676 | 0.160 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 2011 | 892 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2017 | 1942 | 0.160 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 201 | 0.160 |
Why?
|
| Epithelium | 4 | 2015 | 1607 | 0.160 |
Why?
|
| Genome, Human | 1 | 2012 | 4446 | 0.160 |
Why?
|
| Up-Regulation | 4 | 2017 | 4149 | 0.150 |
Why?
|
| Estradiol | 2 | 2017 | 1951 | 0.150 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1998 | 122 | 0.150 |
Why?
|
| Scavenger Receptors, Class B | 4 | 2001 | 85 | 0.150 |
Why?
|
| Stress, Physiological | 2 | 2021 | 1408 | 0.150 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2018 | 89 | 0.150 |
Why?
|
| Fluorescent Dyes | 4 | 1999 | 1931 | 0.150 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2016 | 168 | 0.150 |
Why?
|
| Immunoglobulin M | 8 | 2003 | 1528 | 0.150 |
Why?
|
| Muscle, Skeletal | 9 | 2001 | 4978 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 1996 | 1657 | 0.150 |
Why?
|
| Airway Resistance | 4 | 2004 | 407 | 0.150 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2000 | 169 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2017 | 18065 | 0.150 |
Why?
|
| Peritoneal Lavage | 1 | 2017 | 31 | 0.150 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1998 | 317 | 0.150 |
Why?
|
| Receptor, trkA | 1 | 2018 | 159 | 0.150 |
Why?
|
| Microarray Analysis | 2 | 2018 | 753 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2018 | 317 | 0.140 |
Why?
|
| Sulfoxides | 1 | 2017 | 47 | 0.140 |
Why?
|
| Apoptosis | 6 | 2021 | 9527 | 0.140 |
Why?
|
| Cricetulus | 2 | 2011 | 812 | 0.140 |
Why?
|
| Bacillus anthracis | 1 | 2017 | 120 | 0.140 |
Why?
|
| Integrin beta Chains | 1 | 2017 | 115 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2017 | 48 | 0.140 |
Why?
|
| CHO Cells | 3 | 2011 | 1379 | 0.140 |
Why?
|
| Air Pollution | 3 | 2003 | 2374 | 0.140 |
Why?
|
| Receptors, Somatomedin | 1 | 2017 | 57 | 0.140 |
Why?
|
| Catechin | 1 | 2017 | 70 | 0.140 |
Why?
|
| Genome-Wide Association Study | 4 | 2016 | 12795 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2002 | 744 | 0.140 |
Why?
|
| Leukotriene B4 | 8 | 1993 | 281 | 0.140 |
Why?
|
| Sulfur Dioxide | 3 | 1999 | 178 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3806 | 0.140 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 294 | 0.140 |
Why?
|
| Oxidation-Reduction | 9 | 2007 | 2227 | 0.140 |
Why?
|
| Legionnaires' Disease | 1 | 2016 | 50 | 0.140 |
Why?
|
| Thromboxane B2 | 20 | 1993 | 143 | 0.130 |
Why?
|
| Complement Pathway, Alternative | 4 | 2001 | 113 | 0.130 |
Why?
|
| Mice, Mutant Strains | 5 | 2007 | 1754 | 0.130 |
Why?
|
| Muromonab-CD3 | 1 | 2016 | 104 | 0.130 |
Why?
|
| Reoviridae | 1 | 1996 | 162 | 0.130 |
Why?
|
| Gene Expression | 7 | 2007 | 7601 | 0.130 |
Why?
|
| Benzofurans | 2 | 2016 | 139 | 0.130 |
Why?
|
| Rats, Inbred Strains | 14 | 2006 | 2087 | 0.130 |
Why?
|
| Chemokine CXCL1 | 5 | 2018 | 102 | 0.130 |
Why?
|
| Biological Assay | 2 | 1998 | 628 | 0.130 |
Why?
|
| Diaphragm | 4 | 1998 | 357 | 0.120 |
Why?
|
| Environmental Pollutants | 3 | 2008 | 1296 | 0.120 |
Why?
|
| Receptor, TIE-2 | 1 | 2016 | 183 | 0.120 |
Why?
|
| Toxemia | 1 | 1994 | 14 | 0.120 |
Why?
|
| Administration, Inhalation | 5 | 2009 | 1169 | 0.120 |
Why?
|
| Isoproterenol | 4 | 2001 | 398 | 0.120 |
Why?
|
| Myocardium | 12 | 2003 | 4790 | 0.120 |
Why?
|
| Research Report | 1 | 2018 | 369 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2020 | 540 | 0.120 |
Why?
|
| Fires | 2 | 2013 | 170 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2013 | 3814 | 0.120 |
Why?
|
| Myocardial Contraction | 5 | 2001 | 1526 | 0.120 |
Why?
|
| Muscle Contraction | 8 | 1998 | 1209 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2017 | 539 | 0.120 |
Why?
|
| Complement Activation | 5 | 2003 | 447 | 0.120 |
Why?
|
| Quinolines | 1 | 2020 | 772 | 0.120 |
Why?
|
| Metyrapone | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 154 | 0.120 |
Why?
|
| Pneumococcal Infections | 2 | 2016 | 529 | 0.120 |
Why?
|
| Molecular Sequence Data | 15 | 2005 | 17623 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2018 | 2857 | 0.120 |
Why?
|
| Poly I | 2 | 2008 | 5 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 4 | 1996 | 286 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 384 | 0.120 |
Why?
|
| Lung Diseases | 7 | 2000 | 1944 | 0.120 |
Why?
|
| Chemotactic Factors | 5 | 1996 | 197 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 325 | 0.120 |
Why?
|
| Isoenzymes | 5 | 1999 | 1688 | 0.120 |
Why?
|
| Cluster Analysis | 2 | 2018 | 2732 | 0.110 |
Why?
|
| Indans | 1 | 2014 | 92 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 1995 | 172 | 0.110 |
Why?
|
| Benzodioxoles | 1 | 2014 | 80 | 0.110 |
Why?
|
| Thromboxane A2 | 6 | 1992 | 87 | 0.110 |
Why?
|
| Polystyrenes | 1 | 2014 | 105 | 0.110 |
Why?
|
| Respiratory Mucosa | 2 | 2015 | 439 | 0.110 |
Why?
|
| Cytochalasin D | 2 | 2008 | 91 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2005 | 10763 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2016 | 515 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2014 | 588 | 0.110 |
Why?
|
| Anniversaries and Special Events | 1 | 2014 | 97 | 0.110 |
Why?
|
| Corticosterone | 1 | 2014 | 301 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2019 | 714 | 0.110 |
Why?
|
| Th2 Cells | 4 | 2007 | 1078 | 0.110 |
Why?
|
| Zymosan | 3 | 2011 | 134 | 0.110 |
Why?
|
| Complement System Proteins | 4 | 1999 | 738 | 0.110 |
Why?
|
| Immune System | 1 | 2018 | 800 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4585 | 0.110 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2013 | 57 | 0.110 |
Why?
|
| Spleen | 4 | 2020 | 2296 | 0.100 |
Why?
|
| Oncogenes | 1 | 2018 | 1234 | 0.100 |
Why?
|
| Pulmonary Fibrosis | 2 | 2015 | 506 | 0.100 |
Why?
|
| Interleukin-1 | 8 | 2003 | 1252 | 0.100 |
Why?
|
| Cell Movement | 8 | 2018 | 5213 | 0.100 |
Why?
|
| Fluorescence | 2 | 2009 | 757 | 0.100 |
Why?
|
| Biological Evolution | 1 | 2018 | 1076 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 6 | 2014 | 1613 | 0.100 |
Why?
|
| Deferoxamine | 2 | 2006 | 155 | 0.100 |
Why?
|
| Chelating Agents | 3 | 2006 | 385 | 0.100 |
Why?
|
| Water | 1 | 2019 | 1421 | 0.100 |
Why?
|
| Neutrophil Infiltration | 3 | 2018 | 394 | 0.100 |
Why?
|
| Restraint, Physical | 1 | 2014 | 185 | 0.100 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2004 | 131 | 0.100 |
Why?
|
| Leukocyte Elastase | 1 | 2013 | 114 | 0.100 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 408 | 0.100 |
Why?
|
| Blotting, Western | 8 | 2013 | 5028 | 0.100 |
Why?
|
| Breath Tests | 2 | 2014 | 300 | 0.100 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2021 | 1930 | 0.100 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 619 | 0.100 |
Why?
|
| Prostaglandins E | 3 | 1989 | 166 | 0.100 |
Why?
|
| Membrane Glycoproteins | 5 | 2004 | 3713 | 0.100 |
Why?
|
| Bleomycin | 1 | 2013 | 493 | 0.100 |
Why?
|
| Colony-Stimulating Factors | 2 | 1992 | 218 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1997 | 977 | 0.100 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1892 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 1992 | 132 | 0.100 |
Why?
|
| Acetylcysteine | 3 | 1998 | 262 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 2 | 2013 | 743 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 1996 | 359 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1995 | 553 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2016 | 839 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 8 | 1999 | 1703 | 0.100 |
Why?
|
| Receptors, Complement | 3 | 2001 | 254 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 983 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2016 | 365 | 0.090 |
Why?
|
| Endocytosis | 3 | 2017 | 957 | 0.090 |
Why?
|
| Blotting, Northern | 6 | 2004 | 1553 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 1276 | 0.090 |
Why?
|
| Protein Binding | 3 | 2017 | 9343 | 0.090 |
Why?
|
| Immunohistochemistry | 18 | 2009 | 11095 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 1028 | 0.090 |
Why?
|
| Receptors, Complement 3d | 2 | 2002 | 117 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2010 | 32 | 0.090 |
Why?
|
| Plethysmography, Whole Body | 2 | 2001 | 25 | 0.090 |
Why?
|
| Coculture Techniques | 4 | 2003 | 1344 | 0.090 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 3252 | 0.090 |
Why?
|
| beta Catenin | 1 | 2016 | 1047 | 0.090 |
Why?
|
| Industrial Waste | 2 | 2002 | 24 | 0.090 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 301 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3428 | 0.090 |
Why?
|
| Intestines | 5 | 2003 | 1909 | 0.090 |
Why?
|
| Lyme Disease | 2 | 2017 | 630 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2012 | 3589 | 0.090 |
Why?
|
| Sheep | 10 | 2024 | 1451 | 0.090 |
Why?
|
| Respiratory Function Tests | 5 | 2017 | 1695 | 0.090 |
Why?
|
| Mice, Inbred C3H | 4 | 2005 | 915 | 0.090 |
Why?
|
| Structure-Activity Relationship | 3 | 2016 | 3056 | 0.090 |
Why?
|
| Oligosaccharides | 3 | 2001 | 407 | 0.090 |
Why?
|
| Endothelium, Vascular | 11 | 2016 | 4428 | 0.090 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2010 | 39 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 822 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 348 | 0.090 |
Why?
|
| Adhesins, Bacterial | 1 | 2010 | 118 | 0.090 |
Why?
|
| Endocannabinoids | 2 | 2022 | 113 | 0.090 |
Why?
|
| Decidua | 1 | 2010 | 82 | 0.090 |
Why?
|
| Risk | 4 | 2013 | 9613 | 0.090 |
Why?
|
| Survival Analysis | 4 | 2019 | 10099 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2021 | 2627 | 0.090 |
Why?
|
| Eosinophils | 4 | 2017 | 952 | 0.090 |
Why?
|
| Hyperoxia | 1 | 2012 | 261 | 0.090 |
Why?
|
| Bronchi | 6 | 2007 | 850 | 0.090 |
Why?
|
| Administration, Intranasal | 3 | 2016 | 485 | 0.080 |
Why?
|
| Goblet Cells | 1 | 2013 | 300 | 0.080 |
Why?
|
| Catalase | 4 | 2006 | 215 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2451 | 0.080 |
Why?
|
| Air Pollution, Indoor | 2 | 2011 | 931 | 0.080 |
Why?
|
| Thiourea | 3 | 1999 | 68 | 0.080 |
Why?
|
| Rabbits | 15 | 1998 | 4773 | 0.080 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2012 | 381 | 0.080 |
Why?
|
| Vasodilator Agents | 3 | 2009 | 990 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2040 | 0.080 |
Why?
|
| Immune Tolerance | 2 | 2013 | 2323 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2094 | 0.080 |
Why?
|
| Adolescent | 8 | 2018 | 89169 | 0.080 |
Why?
|
| Edema | 5 | 1999 | 765 | 0.080 |
Why?
|
| Receptors, Leukocyte-Adhesion | 3 | 1995 | 53 | 0.080 |
Why?
|
| Breast Feeding | 2 | 2008 | 1363 | 0.080 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cities | 2 | 2011 | 543 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2009 | 196 | 0.080 |
Why?
|
| Nocodazole | 1 | 2008 | 95 | 0.080 |
Why?
|
| Pyridines | 2 | 2020 | 2894 | 0.080 |
Why?
|
| Child | 7 | 2018 | 80917 | 0.080 |
Why?
|
| Cyclic GMP | 4 | 1998 | 394 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2014 | 1140 | 0.080 |
Why?
|
| Drug Synergism | 2 | 2016 | 1760 | 0.080 |
Why?
|
| Cadherins | 1 | 2013 | 905 | 0.080 |
Why?
|
| Astrocytes | 1 | 2016 | 1350 | 0.080 |
Why?
|
| Arginine | 6 | 1998 | 932 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2459 | 0.080 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 147 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2909 | 0.080 |
Why?
|
| Infant, Newborn | 5 | 2017 | 26421 | 0.070 |
Why?
|
| Cell Separation | 3 | 2013 | 1728 | 0.070 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 106 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1573 | 0.070 |
Why?
|
| Vasculitis | 1 | 2012 | 525 | 0.070 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 344 | 0.070 |
Why?
|
| Weight Loss | 1 | 2019 | 2721 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3772 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2001 | 347 | 0.070 |
Why?
|
| Inhalation | 2 | 2007 | 145 | 0.070 |
Why?
|
| Complement Pathway, Classical | 4 | 2000 | 91 | 0.070 |
Why?
|
| Plasminogen Activators | 1 | 1988 | 199 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2012 | 2674 | 0.070 |
Why?
|
| P-Selectin | 3 | 2000 | 598 | 0.070 |
Why?
|
| Influenza A virus | 1 | 2011 | 460 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2016 | 9561 | 0.070 |
Why?
|
| Muscle, Smooth | 4 | 1997 | 931 | 0.070 |
Why?
|
| Ligands | 4 | 2017 | 3284 | 0.070 |
Why?
|
| Adiponectin | 1 | 2013 | 1117 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2018 | 42669 | 0.070 |
Why?
|
| Hydrochloric Acid | 6 | 2001 | 76 | 0.070 |
Why?
|
| Thionucleotides | 2 | 1997 | 107 | 0.070 |
Why?
|
| Th1 Cells | 3 | 2007 | 1042 | 0.070 |
Why?
|
| Trachea | 5 | 1997 | 1095 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 18415 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2018 | 6283 | 0.070 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 522 | 0.070 |
Why?
|
| Receptors, IgG | 2 | 2014 | 564 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2015 | 4213 | 0.070 |
Why?
|
| Petroleum | 2 | 1998 | 82 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 7609 | 0.070 |
Why?
|
| Pertussis Toxin | 2 | 2004 | 176 | 0.070 |
Why?
|
| Oxygen | 4 | 2003 | 4270 | 0.070 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 137 | 0.070 |
Why?
|
| Sputum | 1 | 2009 | 517 | 0.070 |
Why?
|
| Nitroarginine | 4 | 1998 | 66 | 0.070 |
Why?
|
| Biological Products | 1 | 1996 | 947 | 0.070 |
Why?
|
| Spirometry | 3 | 2014 | 929 | 0.070 |
Why?
|
| Atrioventricular Node | 2 | 1997 | 180 | 0.070 |
Why?
|
| Scattering, Radiation | 2 | 2000 | 489 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2011 | 880 | 0.070 |
Why?
|
| Histocytochemistry | 9 | 1999 | 699 | 0.070 |
Why?
|
| Substance P | 3 | 2001 | 332 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2014 | 2766 | 0.060 |
Why?
|
| Bacteria | 1 | 2017 | 2216 | 0.060 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 292 | 0.060 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2007 | 112 | 0.060 |
Why?
|
| Phenanthridines | 2 | 1999 | 50 | 0.060 |
Why?
|
| Computational Biology | 1 | 2018 | 3567 | 0.060 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 4168 | 0.060 |
Why?
|
| Research | 1 | 2014 | 1979 | 0.060 |
Why?
|
| Hospitals | 1 | 2019 | 3886 | 0.060 |
Why?
|
| Protein Kinase C | 2 | 2008 | 1207 | 0.060 |
Why?
|
| Cattle | 2 | 2024 | 3819 | 0.060 |
Why?
|
| Complement C3 | 7 | 2001 | 434 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 167 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2469 | 0.060 |
Why?
|
| Phosphates | 3 | 1999 | 765 | 0.060 |
Why?
|
| Mast Cells | 3 | 2001 | 1406 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 411 | 0.060 |
Why?
|
| Interleukin-2 | 6 | 1991 | 1895 | 0.060 |
Why?
|
| Metalloendopeptidases | 2 | 1998 | 386 | 0.060 |
Why?
|
| Calcium | 6 | 1999 | 5792 | 0.060 |
Why?
|
| Transplantation, Homologous | 5 | 2004 | 4834 | 0.060 |
Why?
|
| Infant | 5 | 2021 | 36535 | 0.060 |
Why?
|
| Mice, Inbred CBA | 6 | 2004 | 439 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2016 | 2131 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 2007 | 381 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2014 | 9669 | 0.060 |
Why?
|
| Glycoconjugates | 2 | 1995 | 88 | 0.060 |
Why?
|
| L-Selectin | 2 | 1995 | 212 | 0.060 |
Why?
|
| Pulmonary Edema | 6 | 1992 | 408 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 224 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 4 | 2009 | 1605 | 0.060 |
Why?
|
| Adult | 16 | 2018 | 223646 | 0.060 |
Why?
|
| Virus Replication | 2 | 2011 | 2458 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 5 | 1998 | 6124 | 0.060 |
Why?
|
| DNA, Complementary | 4 | 2004 | 1989 | 0.060 |
Why?
|
| Antibody Specificity | 2 | 2003 | 1065 | 0.060 |
Why?
|
| Ferric Compounds | 2 | 1996 | 376 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2001 | 63 | 0.060 |
Why?
|
| Leukocytes | 5 | 2012 | 2034 | 0.060 |
Why?
|
| Young Adult | 5 | 2018 | 60066 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2018 | 8316 | 0.050 |
Why?
|
| COS Cells | 2 | 2010 | 1135 | 0.050 |
Why?
|
| Clostridium Infections | 1 | 2010 | 562 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2015 | 1986 | 0.050 |
Why?
|
| Epitopes | 2 | 2003 | 2527 | 0.050 |
Why?
|
| Cough | 2 | 2017 | 598 | 0.050 |
Why?
|
| Oligonucleotide Probes | 2 | 1995 | 417 | 0.050 |
Why?
|
| RNA Interference | 1 | 2012 | 2832 | 0.050 |
Why?
|
| Myocardial Infarction | 5 | 2014 | 11519 | 0.050 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2003 | 103 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 6 | 2012 | 6082 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1837 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20225 | 0.050 |
Why?
|
| Incineration | 1 | 2002 | 21 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 59626 | 0.050 |
Why?
|
| Nitrites | 2 | 2000 | 156 | 0.050 |
Why?
|
| Milk | 1 | 2006 | 438 | 0.050 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 623 | 0.050 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2004 | 484 | 0.050 |
Why?
|
| Necrosis | 3 | 2021 | 1616 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14729 | 0.050 |
Why?
|
| Caseins | 1 | 2003 | 105 | 0.050 |
Why?
|
| Microtubules | 1 | 2008 | 1064 | 0.050 |
Why?
|
| Cell Adhesion | 7 | 2001 | 3097 | 0.050 |
Why?
|
| Plethysmography | 2 | 1999 | 172 | 0.050 |
Why?
|
| Models, Biological | 2 | 2017 | 9497 | 0.050 |
Why?
|
| Prednisone | 2 | 2017 | 1567 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11677 | 0.050 |
Why?
|
| Amino Acid Sequence | 5 | 1999 | 13422 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 3115 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2003 | 227 | 0.050 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2002 | 241 | 0.050 |
Why?
|
| Drug Combinations | 3 | 2006 | 2089 | 0.050 |
Why?
|
| Smoking | 2 | 2017 | 9092 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8747 | 0.050 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2001 | 36 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2003 | 200 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2016 | 22290 | 0.050 |
Why?
|
| Light | 2 | 2000 | 1355 | 0.050 |
Why?
|
| Receptors, Vitronectin | 1 | 2001 | 48 | 0.050 |
Why?
|
| Receptors, Muscarinic | 3 | 1998 | 157 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2001 | 174 | 0.050 |
Why?
|
| Intestinal Diseases | 2 | 1999 | 505 | 0.050 |
Why?
|
| Mice, Inbred Strains | 4 | 2001 | 1769 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3858 | 0.050 |
Why?
|
| Granulocytes | 1 | 2003 | 551 | 0.050 |
Why?
|
| Phalloidine | 2 | 1991 | 21 | 0.050 |
Why?
|
| Receptors, Complement 3b | 2 | 2000 | 136 | 0.050 |
Why?
|
| Mitochondria | 4 | 1999 | 3683 | 0.050 |
Why?
|
| Air | 2 | 2019 | 187 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4528 | 0.050 |
Why?
|
| Lectins | 3 | 2006 | 490 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2001 | 89 | 0.050 |
Why?
|
| Thromboxane-A Synthase | 6 | 1992 | 34 | 0.050 |
Why?
|
| Pulmonary Circulation | 2 | 1995 | 745 | 0.050 |
Why?
|
| Doxycycline | 2 | 2018 | 349 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2000 | 5505 | 0.050 |
Why?
|
| Risk Factors | 5 | 2008 | 74944 | 0.040 |
Why?
|
| Antimycin A | 2 | 1990 | 31 | 0.040 |
Why?
|
| Leukocyte Count | 10 | 1999 | 1609 | 0.040 |
Why?
|
| Cardiotonic Agents | 2 | 2001 | 543 | 0.040 |
Why?
|
| Receptors, Cannabinoid | 1 | 2020 | 43 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2022 | 244 | 0.040 |
Why?
|
| Interferon Type I | 2 | 2016 | 569 | 0.040 |
Why?
|
| Forced Expiratory Volume | 3 | 2014 | 1831 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 1998 | 243 | 0.040 |
Why?
|
| Vero Cells | 1 | 2021 | 485 | 0.040 |
Why?
|
| Carbachol | 2 | 1997 | 223 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2017 | 267 | 0.040 |
Why?
|
| Cell Count | 3 | 1999 | 1832 | 0.040 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 6 | 1990 | 80 | 0.040 |
Why?
|
| Aging | 2 | 2016 | 8743 | 0.040 |
Why?
|
| Suspensions | 1 | 2000 | 68 | 0.040 |
Why?
|
| Middle Aged | 10 | 2021 | 223487 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1999 | 71 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 1988 | 1738 | 0.040 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 1999 | 51 | 0.040 |
Why?
|
| Clonal Deletion | 1 | 2000 | 75 | 0.040 |
Why?
|
| NF-kappa B | 3 | 2012 | 2494 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2009 | 1294 | 0.040 |
Why?
|
| Thromboxanes | 3 | 1989 | 45 | 0.040 |
Why?
|
| Cell Membrane | 4 | 2013 | 3655 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 17142 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.040 |
Why?
|
| Time Factors | 8 | 2004 | 40220 | 0.040 |
Why?
|
| Aged | 6 | 2021 | 171502 | 0.040 |
Why?
|
| Leg | 3 | 1989 | 1088 | 0.040 |
Why?
|
| Kidney Tubular Necrosis, Acute | 3 | 1988 | 64 | 0.040 |
Why?
|
| Peroxidase | 7 | 1998 | 610 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2003 | 524 | 0.040 |
Why?
|
| Organ Specificity | 3 | 1999 | 1968 | 0.040 |
Why?
|
| Metals | 1 | 2003 | 713 | 0.040 |
Why?
|
| Lung Neoplasms | 5 | 1998 | 13586 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2008 | 2433 | 0.040 |
Why?
|
| Leishmania donovani | 2 | 1996 | 68 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 2885 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2003 | 681 | 0.040 |
Why?
|
| Mesothelioma | 1 | 1985 | 811 | 0.040 |
Why?
|
| Peritoneum | 2 | 2002 | 230 | 0.040 |
Why?
|
| Interleukin-6 | 3 | 1998 | 3229 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 1816 | 0.040 |
Why?
|
| Encephalitis, Viral | 1 | 1999 | 59 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1996 | 1730 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1086 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1999 | 166 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3610 | 0.040 |
Why?
|
| Cholinergic Fibers | 1 | 1998 | 69 | 0.040 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1998 | 89 | 0.040 |
Why?
|
| Chromans | 1 | 1998 | 116 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 1904 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1999 | 816 | 0.040 |
Why?
|
| Propidium | 1 | 1998 | 42 | 0.040 |
Why?
|
| Superoxides | 2 | 1990 | 389 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 996 | 0.040 |
Why?
|
| DNA | 1 | 1992 | 7213 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2017 | 1542 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2009 | 5804 | 0.040 |
Why?
|
| Ethanolamines | 1 | 1998 | 152 | 0.040 |
Why?
|
| Sinoatrial Node | 1 | 1998 | 99 | 0.040 |
Why?
|
| Pulmonary Atelectasis | 2 | 1992 | 160 | 0.040 |
Why?
|
| Orosomucoid | 1 | 1997 | 45 | 0.040 |
Why?
|
| Receptors, Interleukin-3 | 1 | 1997 | 29 | 0.040 |
Why?
|
| Epoprostenol | 3 | 1989 | 246 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2006 | 2914 | 0.040 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 13013 | 0.040 |
Why?
|
| Norepinephrine | 2 | 1998 | 898 | 0.040 |
Why?
|
| Cannabinoids | 1 | 2020 | 174 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 503 | 0.040 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 1997 | 41 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 1998 | 286 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2002 | 1419 | 0.040 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 64 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2012 | 6610 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1997 | 131 | 0.040 |
Why?
|
| Cell Communication | 2 | 2002 | 1660 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1999 | 375 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1998 | 203 | 0.030 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1997 | 115 | 0.030 |
Why?
|
| Nitroso Compounds | 1 | 1997 | 71 | 0.030 |
Why?
|
| Neprilysin | 2 | 1997 | 487 | 0.030 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1996 | 46 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 1998 | 247 | 0.030 |
Why?
|
| Simplexvirus | 2 | 1998 | 805 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1996 | 3740 | 0.030 |
Why?
|
| Proteins | 5 | 1992 | 6009 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 325 | 0.030 |
Why?
|
| Reperfusion | 6 | 1997 | 266 | 0.030 |
Why?
|
| omega-N-Methylarginine | 4 | 1998 | 108 | 0.030 |
Why?
|
| Lymphocytes | 3 | 2015 | 2614 | 0.030 |
Why?
|
| Legionella pneumophila | 1 | 2016 | 50 | 0.030 |
Why?
|
| Enzyme Induction | 4 | 1998 | 455 | 0.030 |
Why?
|
| Methacrylates | 7 | 1992 | 110 | 0.030 |
Why?
|
| Complement Inactivator Proteins | 3 | 2001 | 74 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 1996 | 18 | 0.030 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1976 | 62 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 243 | 0.030 |
Why?
|
| Caveolins | 1 | 1996 | 102 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2016 | 69 | 0.030 |
Why?
|
| Dopamine | 2 | 2022 | 1592 | 0.030 |
Why?
|
| Serotyping | 1 | 1996 | 331 | 0.030 |
Why?
|
| Surface Properties | 1 | 2019 | 1166 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1996 | 339 | 0.030 |
Why?
|
| Proteolipids | 1 | 1996 | 112 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 1197 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 1999 | 677 | 0.030 |
Why?
|
| Peritonitis | 1 | 1998 | 368 | 0.030 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1976 | 171 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1998 | 619 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 3 | 1998 | 2004 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1998 | 594 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 1995 | 124 | 0.030 |
Why?
|
| Reticulocytes | 1 | 1996 | 287 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2057 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 1999 | 709 | 0.030 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 1065 | 0.030 |
Why?
|
| Complement C5 | 3 | 1999 | 104 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 2 | 2009 | 283 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2016 | 1497 | 0.030 |
Why?
|
| Asbestos, Serpentine | 1 | 2015 | 24 | 0.030 |
Why?
|
| Printing | 1 | 2015 | 47 | 0.030 |
Why?
|
| Calcium Channels | 2 | 1996 | 623 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 1997 | 296 | 0.030 |
Why?
|
| Leukopenia | 5 | 1995 | 212 | 0.030 |
Why?
|
| Instillation, Drug | 1 | 1995 | 32 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3474 | 0.030 |
Why?
|
| Models, Animal | 1 | 2001 | 2122 | 0.030 |
Why?
|
| Sphincter of Oddi | 1 | 1994 | 21 | 0.030 |
Why?
|
| Glycolysis | 1 | 1999 | 837 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 694 | 0.030 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1976 | 289 | 0.030 |
Why?
|
| Lymph | 3 | 1991 | 78 | 0.030 |
Why?
|
| Superoxide Dismutase | 4 | 1992 | 596 | 0.030 |
Why?
|
| Stromal Cells | 2 | 1998 | 1337 | 0.030 |
Why?
|
| Acute Kidney Injury | 4 | 1989 | 1942 | 0.030 |
Why?
|
| Arginase | 1 | 2015 | 81 | 0.030 |
Why?
|
| Complement Factor I | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2001 | 843 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 2003 | 3044 | 0.030 |
Why?
|
| Genes, Retinoblastoma | 1 | 1995 | 125 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1346 | 0.030 |
Why?
|
| Kidney | 6 | 1993 | 7064 | 0.030 |
Why?
|
| Proteome | 1 | 2024 | 1890 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1994 | 141 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5997 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1994 | 220 | 0.030 |
Why?
|
| Luciferases | 1 | 1996 | 713 | 0.030 |
Why?
|
| Codon | 1 | 1996 | 599 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10840 | 0.030 |
Why?
|
| Listeria monocytogenes | 2 | 2007 | 246 | 0.030 |
Why?
|
| Bronchoconstriction | 1 | 1995 | 141 | 0.030 |
Why?
|
| E-Selectin | 2 | 2012 | 577 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 579 | 0.030 |
Why?
|
| Complement C4 | 3 | 2001 | 216 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 1995 | 612 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2016 | 293 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3445 | 0.030 |
Why?
|
| Phenotype | 3 | 2016 | 16726 | 0.030 |
Why?
|
| NADPH Dehydrogenase | 1 | 1993 | 44 | 0.030 |
Why?
|
| Thymine DNA Glycosylase | 1 | 2013 | 7 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1999 | 1864 | 0.030 |
Why?
|
| Radiation Chimera | 3 | 1998 | 216 | 0.030 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1994 | 179 | 0.030 |
Why?
|
| Cell Membrane Permeability | 3 | 2001 | 573 | 0.030 |
Why?
|
| Polyenes | 1 | 1993 | 68 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65379 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1976 | 648 | 0.030 |
Why?
|
| Serine Endopeptidases | 2 | 2001 | 1027 | 0.030 |
Why?
|
| Histamine | 1 | 1995 | 496 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 1998 | 5432 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 2 | 2007 | 77 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 1996 | 960 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1996 | 855 | 0.030 |
Why?
|
| Heart | 2 | 1998 | 4446 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 218 | 0.030 |
Why?
|
| Adsorption | 1 | 2013 | 198 | 0.030 |
Why?
|
| Interferons | 1 | 1996 | 720 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2012 | 42 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 866 | 0.030 |
Why?
|
| Tretinoin | 1 | 1995 | 525 | 0.030 |
Why?
|
| Immunoglobulin G | 3 | 2007 | 4568 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 21207 | 0.030 |
Why?
|
| Pancreatic Elastase | 1 | 1992 | 125 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 369 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2018 | 724 | 0.020 |
Why?
|
| Metaplasia | 1 | 2013 | 326 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2005 | 2029 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1998 | 1478 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1998 | 6229 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 669 | 0.020 |
Why?
|
| Ascitic Fluid | 2 | 1998 | 189 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1992 | 223 | 0.020 |
Why?
|
| Graft vs Host Disease | 3 | 2000 | 3049 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 363 | 0.020 |
Why?
|
| Capillaries | 1 | 1994 | 755 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1996 | 2202 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 642 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2013 | 577 | 0.020 |
Why?
|
| Renal Circulation | 2 | 1989 | 291 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15949 | 0.020 |
Why?
|
| Transgenes | 2 | 2005 | 1016 | 0.020 |
Why?
|
| Clostridium sordellii | 1 | 2010 | 3 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2661 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.020 |
Why?
|
| Permeability | 4 | 1996 | 726 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2012 | 259 | 0.020 |
Why?
|
| Selectins | 2 | 2001 | 101 | 0.020 |
Why?
|
| Virion | 1 | 2013 | 429 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 1972 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2013 | 996 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1995 | 1062 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1990 | 72 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2014 | 560 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2001 | 2138 | 0.020 |
Why?
|
| Lung Transplantation | 1 | 2000 | 1309 | 0.020 |
Why?
|
| Denmark | 1 | 2012 | 776 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2003 | 3941 | 0.020 |
Why?
|
| Enzyme Inhibitors | 5 | 1998 | 3728 | 0.020 |
Why?
|
| Sodium | 1 | 1995 | 1597 | 0.020 |
Why?
|
| Haplotypes | 1 | 2016 | 2722 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1397 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1999 | 3782 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 13045 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 1712 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2009 | 9384 | 0.020 |
Why?
|
| Graft Rejection | 2 | 2000 | 4492 | 0.020 |
Why?
|
| Progesterone | 1 | 2014 | 752 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 693 | 0.020 |
Why?
|
| Platelet Count | 5 | 1991 | 787 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 1999 | 2211 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2009 | 98 | 0.020 |
Why?
|
| Ibuprofen | 5 | 1989 | 229 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4280 | 0.020 |
Why?
|
| Gene Library | 1 | 1992 | 1064 | 0.020 |
Why?
|
| Benzamides | 1 | 1995 | 1379 | 0.020 |
Why?
|
| Esophagus | 1 | 1995 | 1042 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 640 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2013 | 744 | 0.020 |
Why?
|
| Immunochemistry | 2 | 1985 | 116 | 0.020 |
Why?
|
| Multigene Family | 1 | 1992 | 1081 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 1991 | 391 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2474 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1995 | 1880 | 0.020 |
Why?
|
| Heart Ventricles | 5 | 2001 | 3841 | 0.020 |
Why?
|
| Logistic Models | 2 | 2014 | 13290 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 966 | 0.020 |
Why?
|
| Transfection | 2 | 1996 | 5756 | 0.020 |
Why?
|
| RNA | 1 | 1998 | 2722 | 0.020 |
Why?
|
| Liver | 3 | 2017 | 7578 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2018 | 2935 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 582 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1988 | 351 | 0.020 |
Why?
|
| Toll-Like Receptors | 2 | 2004 | 582 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2013 | 876 | 0.020 |
Why?
|
| DNA Primers | 2 | 2007 | 2828 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1999 | 2145 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 2007 | 18 | 0.020 |
Why?
|
| Toluene 2,4-Diisocyanate | 1 | 2007 | 13 | 0.020 |
Why?
|
| Lung Compliance | 2 | 1998 | 207 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3436 | 0.020 |
Why?
|
| Piperazines | 1 | 1998 | 2554 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 1582 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 6019 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2008 | 0.020 |
Why?
|
| Indomethacin | 1 | 1988 | 323 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 1996 | 940 | 0.020 |
Why?
|
| Irritants | 1 | 2007 | 43 | 0.020 |
Why?
|
| Epigenomics | 1 | 2013 | 960 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1985 | 6395 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 609 | 0.020 |
Why?
|
| Matrix Metalloproteinase 11 | 2 | 1998 | 15 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2007 | 366 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 377 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 1998 | 213 | 0.020 |
Why?
|
| Diethylcarbamazine | 3 | 1992 | 23 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1951 | 0.020 |
Why?
|
| Granuloma | 1 | 2009 | 329 | 0.020 |
Why?
|
| Listeriosis | 1 | 2007 | 147 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1988 | 564 | 0.020 |
Why?
|
| Free Radicals | 3 | 1992 | 238 | 0.020 |
Why?
|
| Elastin | 1 | 1988 | 299 | 0.020 |
Why?
|
| Piperidines | 1 | 1995 | 1667 | 0.020 |
Why?
|
| Capsaicin | 2 | 1999 | 235 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2540 | 0.020 |
Why?
|
| Staphylococcal Protein A | 1 | 1985 | 39 | 0.020 |
Why?
|
| Body Weight | 1 | 2017 | 4627 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2634 | 0.020 |
Why?
|
| Fixatives | 1 | 1985 | 90 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2798 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1989 | 2560 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2002 | 1379 | 0.020 |
Why?
|
| Animals, Congenic | 1 | 2005 | 27 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 3623 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2414 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 1524 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1995 | 4178 | 0.020 |
Why?
|
| Microcirculation | 3 | 1998 | 1281 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 2006 | 193 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 693 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1988 | 597 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6894 | 0.020 |
Why?
|
| Family Health | 1 | 2010 | 1255 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2000 | 4206 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1080 | 0.010 |
Why?
|
| Membranes | 2 | 1995 | 164 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1752 | 0.010 |
Why?
|
| Eosinophilia | 2 | 2000 | 556 | 0.010 |
Why?
|
| Chromosomes | 1 | 2007 | 578 | 0.010 |
Why?
|
| Acute Disease | 1 | 1995 | 7243 | 0.010 |
Why?
|
| Organ Size | 3 | 1999 | 2267 | 0.010 |
Why?
|
| Health Surveys | 1 | 2014 | 4057 | 0.010 |
Why?
|
| Uteroglobin | 1 | 2004 | 56 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20762 | 0.010 |
Why?
|
| Respiratory Transport | 1 | 2003 | 8 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 2003 | 13 | 0.010 |
Why?
|
| Hemodynamics | 3 | 1989 | 4194 | 0.010 |
Why?
|
| Cell Division | 2 | 2004 | 4477 | 0.010 |
Why?
|
| Tetracycline | 1 | 2004 | 216 | 0.010 |
Why?
|
| Kinetics | 3 | 1998 | 6330 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2018 | 2666 | 0.010 |
Why?
|
| Lymphokines | 1 | 1986 | 925 | 0.010 |
Why?
|
| Respiratory Insufficiency | 2 | 1989 | 1240 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2003 | 147 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1995 | 1309 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10478 | 0.010 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2003 | 139 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10632 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1990 | 1281 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8741 | 0.010 |
Why?
|
| Syndrome | 2 | 2000 | 3273 | 0.010 |
Why?
|
| Protease Inhibitors | 2 | 1997 | 751 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 611 | 0.010 |
Why?
|
| Imidazoles | 3 | 1998 | 1169 | 0.010 |
Why?
|
| Bronchopulmonary Sequestration | 2 | 1992 | 43 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1985 | 344 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4352 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1985 | 791 | 0.010 |
Why?
|
| Gold | 1 | 1985 | 488 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 4939 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1716 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2003 | 251 | 0.010 |
Why?
|
| Nitroprusside | 2 | 1995 | 272 | 0.010 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2001 | 15 | 0.010 |
Why?
|
| Chymases | 1 | 2001 | 84 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1985 | 2300 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2001 | 34 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 2002 | 406 | 0.010 |
Why?
|
| Bacteremia | 2 | 1998 | 985 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1996 | 3466 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12077 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2003 | 564 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 794 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1986 | 535 | 0.010 |
Why?
|
| Bronchodilator Agents | 1 | 2004 | 518 | 0.010 |
Why?
|
| Respiration | 2 | 1997 | 1665 | 0.010 |
Why?
|
| Blood Pressure | 6 | 1994 | 8543 | 0.010 |
Why?
|
| Pleural Neoplasms | 1 | 1985 | 612 | 0.010 |
Why?
|
| Complement C3b | 1 | 2000 | 98 | 0.010 |
Why?
|
| Lysosomes | 1 | 1985 | 938 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2004 | 721 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1683 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2000 | 50 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1401 | 0.010 |
Why?
|
| Nasal Lavage Fluid | 1 | 1999 | 17 | 0.010 |
Why?
|
| Complement C5a | 1 | 1999 | 100 | 0.010 |
Why?
|
| United States | 2 | 2018 | 73039 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 1993 | 3301 | 0.010 |
Why?
|
| Genes, RAG-1 | 1 | 1999 | 68 | 0.010 |
Why?
|
| Autoantibodies | 2 | 2000 | 2121 | 0.010 |
Why?
|
| Tachykinins | 1 | 1999 | 77 | 0.010 |
Why?
|
| Critical Illness | 1 | 2012 | 2755 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2018 | 12171 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1998 | 100 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2000 | 348 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2000 | 287 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 154 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1998 | 102 | 0.010 |
Why?
|
| Biopsy | 2 | 2001 | 6792 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1998 | 166 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 739 | 0.010 |
Why?
|
| Isoantigens | 1 | 2000 | 562 | 0.010 |
Why?
|
| Liver Diseases | 3 | 1991 | 1305 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1997 | 28 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2000 | 588 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1999 | 210 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1998 | 60 | 0.010 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2000 | 221 | 0.010 |
Why?
|
| Receptors, Interleukin-5 | 1 | 1997 | 20 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1998 | 115 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 321 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1998 | 143 | 0.010 |
Why?
|
| Aminoquinolines | 1 | 1998 | 105 | 0.010 |
Why?
|
| Hydrazines | 2 | 1989 | 223 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1998 | 328 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1998 | 315 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1999 | 527 | 0.010 |
Why?
|
| Histocompatibility | 1 | 1998 | 321 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2000 | 518 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1997 | 114 | 0.010 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 1997 | 23 | 0.010 |
Why?
|
| Neurons | 1 | 1997 | 9514 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 175 | 0.010 |
Why?
|
| Calmodulin | 1 | 1998 | 241 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1998 | 205 | 0.010 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1997 | 93 | 0.010 |
Why?
|
| Penicillamine | 1 | 1997 | 60 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 1997 | 65 | 0.010 |
Why?
|
| Vitronectin | 1 | 1996 | 40 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1999 | 446 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 14164 | 0.010 |
Why?
|
| Guanidines | 1 | 1998 | 194 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1998 | 206 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1996 | 58 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1992 | 2230 | 0.010 |
Why?
|
| Factor X | 1 | 1996 | 64 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 1996 | 75 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16044 | 0.010 |
Why?
|
| Molsidomine | 1 | 1996 | 22 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 1996 | 174 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1997 | 317 | 0.010 |
Why?
|
| Antigens, CD19 | 1 | 2000 | 446 | 0.010 |
Why?
|
| Agglutinins | 1 | 1976 | 28 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 1996 | 50 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 1999 | 365 | 0.010 |
Why?
|
| Housing | 1 | 2001 | 683 | 0.010 |
Why?
|
| Pulmonary Artery | 3 | 1991 | 1946 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1998 | 605 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1976 | 87 | 0.010 |
Why?
|
| Recurrence | 1 | 2009 | 8509 | 0.010 |
Why?
|
| Cryoglobulins | 1 | 1976 | 58 | 0.010 |
Why?
|
| Nitrates | 1 | 1998 | 260 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1989 | 542 | 0.010 |
Why?
|
| Catalysis | 1 | 1998 | 768 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1976 | 342 | 0.010 |
Why?
|
| Bronchoscopes | 1 | 1996 | 64 | 0.010 |
Why?
|
| Indazoles | 1 | 1998 | 306 | 0.010 |
Why?
|
| Kidney Diseases | 3 | 1991 | 2100 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1976 | 340 | 0.010 |
Why?
|
| Biological Clocks | 1 | 1998 | 321 | 0.010 |
Why?
|
| Meningitis, Bacterial | 1 | 1998 | 225 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1999 | 841 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2001 | 1194 | 0.010 |
Why?
|
| Pyrilamine | 1 | 1995 | 13 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1996 | 324 | 0.010 |
Why?
|
| Receptors, Neurokinin-2 | 1 | 1995 | 24 | 0.010 |
Why?
|
| Autoantigens | 1 | 2000 | 890 | 0.010 |
Why?
|
| Receptors, Histamine | 1 | 1995 | 23 | 0.010 |
Why?
|
| Premedication | 2 | 1987 | 246 | 0.010 |
Why?
|
| Dipeptides | 1 | 1997 | 386 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1998 | 1266 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1996 | 331 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1995 | 216 | 0.010 |
Why?
|
| Vaccination | 1 | 2007 | 3437 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1890 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1976 | 525 | 0.010 |
Why?
|
| Atropine | 1 | 1995 | 244 | 0.010 |
Why?
|
| Calcitriol | 1 | 1996 | 303 | 0.010 |
Why?
|
| Heart Failure | 1 | 1999 | 11879 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2645 | 0.010 |
Why?
|
| Caveolin 1 | 1 | 1996 | 255 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 169 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1976 | 355 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2000 | 1599 | 0.010 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 1995 | 133 | 0.010 |
Why?
|
| Electrolytes | 1 | 1995 | 279 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 3517 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 4249 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 320 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1995 | 657 | 0.010 |
Why?
|
| Fiber Optic Technology | 1 | 1996 | 290 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1985 | 4913 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 775 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1994 | 411 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1393 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1435 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 299 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 1034 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2000 | 914 | 0.010 |
Why?
|
| Fibrin | 1 | 1996 | 514 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1997 | 663 | 0.010 |
Why?
|
| Mechlorethamine | 1 | 1993 | 129 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1993 | 231 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1976 | 252 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 2939 | 0.010 |
Why?
|
| Mucus | 1 | 1995 | 346 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2000 | 837 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 2173 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1994 | 646 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 1995 | 429 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2541 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1996 | 891 | 0.010 |
Why?
|
| Nasopharynx | 1 | 1996 | 420 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1999 | 2004 | 0.010 |
Why?
|
| Hormones | 1 | 1997 | 866 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 26379 | 0.010 |
Why?
|
| Evans Blue | 1 | 1992 | 42 | 0.010 |
Why?
|
| Creatinine | 2 | 1989 | 1918 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1996 | 1751 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 1992 | 149 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2085 | 0.010 |
Why?
|
| Genes | 1 | 1976 | 1824 | 0.010 |
Why?
|
| Mucins | 1 | 1995 | 570 | 0.010 |
Why?
|
| Dogs | 2 | 1987 | 3845 | 0.010 |
Why?
|
| Granzymes | 1 | 1993 | 277 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 1993 | 521 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1993 | 297 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1992 | 250 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1995 | 1648 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 710 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 2421 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1993 | 1163 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2000 | 1885 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1992 | 186 | 0.010 |
Why?
|
| Tourniquets | 1 | 1992 | 111 | 0.010 |
Why?
|
| Edema, Cardiac | 1 | 1991 | 19 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 671 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1991 | 181 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1726 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1995 | 1134 | 0.010 |
Why?
|
| Fatty Alcohols | 1 | 1990 | 22 | 0.010 |
Why?
|
| Glycols | 1 | 1990 | 54 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12840 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1992 | 425 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1996 | 1162 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 5047 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1992 | 912 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1990 | 341 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1990 | 305 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1995 | 1741 | 0.010 |
Why?
|
| Receptors, Thromboxane | 1 | 1989 | 30 | 0.010 |
Why?
|
| Receptors, Prostaglandin | 1 | 1989 | 53 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1993 | 680 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1990 | 155 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1744 | 0.010 |
Why?
|
| Rosette Formation | 1 | 1989 | 152 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3590 | 0.010 |
Why?
|
| Renal Veins | 1 | 1989 | 103 | 0.000 |
Why?
|
| Eicosanoids | 1 | 1990 | 284 | 0.000 |
Why?
|
| Action Potentials | 1 | 1996 | 1838 | 0.000 |
Why?
|
| Sulfonamides | 1 | 1998 | 1982 | 0.000 |
Why?
|
| Blood | 1 | 1991 | 599 | 0.000 |
Why?
|
| Ovarian Neoplasms | 1 | 1985 | 4916 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1999 | 2907 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1996 | 1359 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1999 | 3124 | 0.000 |
Why?
|
| Disease Progression | 1 | 2005 | 13668 | 0.000 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 479 | 0.000 |
Why?
|
| Allopurinol | 1 | 1989 | 202 | 0.000 |
Why?
|
| Fistula | 1 | 1989 | 213 | 0.000 |
Why?
|
| Renal Artery Obstruction | 1 | 1988 | 217 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1989 | 796 | 0.000 |
Why?
|
| Plasma | 1 | 1990 | 585 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1437 | 0.000 |
Why?
|
| Sirolimus | 1 | 1993 | 1540 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 2726 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1987 | 398 | 0.000 |
Why?
|
| Carrageenan | 1 | 1985 | 71 | 0.000 |
Why?
|
| Receptors, Fc | 1 | 1989 | 537 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1627 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1987 | 838 | 0.000 |
Why?
|
| Lung Volume Measurements | 1 | 1986 | 381 | 0.000 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 1999 | 4648 | 0.000 |
Why?
|
| Blood Gas Analysis | 1 | 1986 | 384 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 3604 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15453 | 0.000 |
Why?
|
| Lymph Node Excision | 1 | 1989 | 1271 | 0.000 |
Why?
|
| Graft Survival | 1 | 1993 | 3887 | 0.000 |
Why?
|
| Insulin | 1 | 1995 | 6610 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 5704 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1990 | 2819 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 41753 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1985 | 1398 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2000 | 81760 | 0.000 |
Why?
|
| Brain | 1 | 1997 | 27362 | 0.000 |
Why?
|